Screening rules
Why it screened this way
✗
No hard-rule violations detected.
NSEPharmaceuticalsIndia
Glenmark Pharmaceuticals Limited
Cautious₹2,084
-0.81% today · Day ₹1,967 – ₹2,098 · NSE (public)
We can't fully confirm this stock yet — it needs a manual check by a scholar or compliance expert.
100/100
Cautious
We can't fully confirm this stock yet — it needs a manual check by a scholar or compliance expert.
Market Cap₹59,051
Revenue₹13,146
Total Debt₹2,473
Debt / Mcap4.65%
Non-Halal Income0.33%
SectorPharmaceuticals
Price Chart
Loading chart...
52-Week Range78% from low
52-Week Low₹1,336
52-Week High₹2,298
Prev Close₹2,101
Multi-Methodology Screening
Screened against 3 international Shariah standards
ConsensusCautious0/3 pass
S&P Shariah IndicesCautious
Debt Ratio4.7%/ 33.0%
Non-Halal Income0.3%/ 5.0%
Interest Income0.3%/ 5.0%
Receivables5.7%/ 33.0%
Cash & IB Securities10.5%/ 33.0%
SectorAllowed
AAOIFI StandardsCautious
Debt Ratio15.4%/ 30.0%
Non-Halal Income0.3%/ 5.0%
Interest Income0.3%/ 5.0%
Receivables20.8%/ 49.0%
Cash & IB Securities10.5%/ 30.0%
SectorAllowed
FTSE Yasaar (Maxis)Cautious
Debt Ratio15.4%/ 33.0%
Non-Halal Income0.3%/ 5.0%
Interest Income0.3%/ 5.0%
Receivables20.8%/ 50.0%
Cash & IB Securities10.5%/ 33.0%
SectorAllowed
Each methodology uses different denominators and thresholds. A stock may be compliant under one standard but not another. The consensus reflects the majority verdict across all three.
Compliance check
Green = safe, amber = close to limit, red = over the limit
Debt level
4.65%Current debt
4.19%Income purity
0.33%Interest earned
0.33%Similar stocks
Other stocks in Pharmaceuticals